99 related articles for article (PubMed ID: 3158445)
1. [Effect of ilexonin A on platelet function and ultrastructure].
Wang Z; Du JX
Zhong Xi Yi Jie He Za Zhi; 1985 Apr; 5(4):232-4, 197. PubMed ID: 3158445
[No Abstract] [Full Text] [Related]
2. [Effect of ilexonin A on plasma euglobulin lysis and platelet aggregation].
Liu GD; Hu ZJ; Zhong CN
Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):185-7. PubMed ID: 6239511
[No Abstract] [Full Text] [Related]
3. [Current pharmacological aspects of antithrombotic drugs].
Stroescu V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):325-7. PubMed ID: 14367
[No Abstract] [Full Text] [Related]
4. [Fundamental principles of hemostasis--oral antiplatelets and anticoagulants].
Morais D; Maranda G
J Dent Que; 1987 Apr; 24():201-7. PubMed ID: 3298345
[No Abstract] [Full Text] [Related]
5. Effects of ilexonin A on cAMP metabolism in platelets.
Wang Z; Li F
Chin Med Sci J; 1993 Dec; 8(4):215-7. PubMed ID: 8032067
[TBL] [Abstract][Full Text] [Related]
6. Changes in platelet reactivity, prostacyclin and thromboxane production after long-term oral defibrotide in healthy and atherosclerotic rabbits.
Löbel P; Palmér M; Schrör K
Prog Clin Biol Res; 1987; 242():265-70. PubMed ID: 3313414
[No Abstract] [Full Text] [Related]
7. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
Baumgartner HR
Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
[No Abstract] [Full Text] [Related]
8. Anticoagulant and antiplatelet properties of piracetam.
Teng CM; Yeh HI; Lee LG
Taiwan Yi Xue Hui Za Zhi; 1983 Nov; 82(11):1104-14. PubMed ID: 6584538
[No Abstract] [Full Text] [Related]
9. [Effect of drugs used in the treatment of thrombotic and hemorrhagic conditions on the erythrocyte aggregation].
Lakin KM; Ovnatanova MS
Kardiologiia; 1977 May; 17(5):79-83. PubMed ID: 886757
[No Abstract] [Full Text] [Related]
10. Effect of procainamide on ultrastructure of blood platelet in rabbits.
Liu LP; Shan CW; Liu XH; Xiao HC; Yang SQ
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):376-9. PubMed ID: 10375789
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet function by antithrombotic agents which selectively inhibit low-Km cyclic 3',5'-adenosine monophosphate phosphodiesterase.
Tang SS; Frojmovic MM
J Lab Clin Med; 1980 Feb; 95(2):241-57. PubMed ID: 6243686
[No Abstract] [Full Text] [Related]
13. [Ilexonin A may be a slow calcium channel blocker].
Wang L; Wang Z
Zhong Xi Yi Jie He Za Zhi; 1989 Nov; 9(11):668-71, 645. PubMed ID: 2611956
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate.
Li M; Wu WK; Liu L; Liao FL; Shinohara Y; Handa S; Goto S
Chin Med J (Engl); 2004 Feb; 117(2):241-6. PubMed ID: 14975210
[TBL] [Abstract][Full Text] [Related]
15. Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
Zhang L; Wang J; Yu M; Ru B
Mol Genet Metab; 2004 Aug; 82(4):304-11. PubMed ID: 15308128
[TBL] [Abstract][Full Text] [Related]
16. Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics.
Cheng-Ching E; Samaniego EA; Naravetla BR; Zaidat OO; Hussain MS
Neurology; 2012 Sep; 79(13 Suppl 1):S68-76. PubMed ID: 23008416
[TBL] [Abstract][Full Text] [Related]
17. A new function for the calcineurin b subunit: antiplatelet aggregation and anticoagulation.
Su Z; Xin S; Li J; Guo J; Long X; Cheng J; Wei Q
IUBMB Life; 2011 Nov; 63(11):1037-44. PubMed ID: 22031497
[TBL] [Abstract][Full Text] [Related]
18. [Antithrombotic activity of RU-891 antiaggregant agent].
Spasov AA; Kucheriavenko AF; Tian' M; Anisimova VA
Eksp Klin Farmakol; 2013; 76(6):25-6. PubMed ID: 24003486
[TBL] [Abstract][Full Text] [Related]
19. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
Lakin KM; Makarow WA; Mular AG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
[TBL] [Abstract][Full Text] [Related]
20. [Systemic effects of thrombolytic therapy].
Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
